ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 321

Evaluation and Comparison Of Performance Of Different Classification Criteria For Reactive Arthritis

Mariana Benegas1, Rafael Chaparro1, Oscar L. Rillo2, Luciana Casalla1, Emilce Schneeberger3, Federico Ceccatto4, Sergio Paira5, Federico Zazzetti6, Juan C. Barreira7 and Emilio Busquiazzo8, 1Rheumatology, Hospital Gral. de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 2Rheumatology Unit, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 3Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 4Rheumatology, Hospital Jose María Cullen, Santa Fé, Argentina, 5Hospital Jose María Cullen, Santa Fé, Argentina, 6Rheumatology, Hospital Británico, Buenos Aires, Argentina, 7Rheumatology, British Hospital, Buenos Aires, Argentina, 8Rheumatology, Hospital del Milagro, Salta, Argentina

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Classification criteria and reactive arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: Psoriatic Arthritis: Clinical Aspects and Treatment I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Reactive Arthritis (Re.A) is an inflammatory joint disease that according to different records represents from 6% to 47% of the seronegative spondyloarthropathies (SS). These differences may be due to genetic and/or environmental variations as well as the absence of an agreement on the definition of case and validated classification criteria. Objective: to assess and compare the diagnostic value of the classification criteria for Re.A in a cohort patients.

Methods: consecutive adult patients (≥18 years old) were included from 5 Argentinian centers, with Re.A diagnosed by rheumatologists with broad experience in this entity, and as a control group, patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Clinical data, laboratory and radiological characteristics employed by the different criteria were retro-prospectively collected and recorded. We classified each patient according to different classification criteria: Calin, Third International Workshop of ReA, American College of Rheumatology (ACR), European Spondylarthropathy Study Group (ESSG), Amor and Assessment of Spondyloarthritis international Society (ASAS) for peripheral arthritis, having registered their fulfillment. Statistical analysis: we described the variables under study. Sensitivity, specificity, positive and negative predictive value (PPV/NPV) and likelihood ratios (LR) for each criteria were assessed by double entry table.

Results: thirty six patients with Re.A (78% male), were included, median age (SD): 36 (12) years, median (IQR) disease duration: 22 (2-444) months. Fifty-six percent presented urethritis, 28% gastroenteritis, 8% cervicitis and 8% other infections. Forty-four, 33 and 17% had mono, oligo y polyarthritis respectively, 86% asymmetrical and 61% predominant in lower limbs. Inflammatory spinal pain and sacroiliitis were detected in 56% and 36% respectively; enthesitis 50% and dactylitis 14%. Extra-articular manifestations: uveitis 17%, conjunctivitis and balanitis 8%, keratoderma blennorrhagica and genital ulcer 3%. Radiographic features: 30% had sacroiliitis. In the control group 36 patients (16 PsA, 15 RA, 5 AS) were evaluated; they had similar demographic characteristics and typical findings of each of these entities. The following table shows the sensitivity, specificity, PPV, NPV and LR obtained by the different classification criteria:

 

Calin

ACR

Amor

ESSG

ASAS

3° Workshop

 Sensitivity (%)

81

64

53

97

97

64

 Specificity (%)

100

100

47

57

50

100

 PV (%) +

100

54

50

69

66

100

 PV (%)  –

84

73

50

95

95

73

 LR

∞

∞

1

2.19

1.94

∞

Conclusion:  the highest sensitivity was observed by applying the ESSG, ASAS and Calin criteria. The highest specificity was obtained by applying the Calin, ACR and Third International Workshop criteria. We observe, in this study, that Calin’s criteria showed excellent specificity, keeping a good sensitivity and high positive predictive values and likelihood ratios.


Disclosure:

M. Benegas,
None;

R. Chaparro,
None;

O. L. Rillo,
None;

L. Casalla,
None;

E. Schneeberger,
None;

F. Ceccatto,
None;

S. Paira,
None;

F. Zazzetti,
None;

J. C. Barreira,
None;

E. Busquiazzo,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-and-comparison-of-performance-of-different-classification-criteria-for-reactive-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology